Jagsonpal Pharmaceuticals Ltd: Financial Statements & Historical Data

Jagsonpal Pharmaceuticals Ltd: Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 7.9% to ₹82 crore against Jun 2025. Net profit rose 18.2% to ₹13 crore against the same period a year earlier. Operating margin rose from 18.4% to 20.7% (2.3 percentage points higher). For the full year ending Mar 2026, operating margin improved to 20.2%.

Calculated from the stored statements below · Reporting periods remain separate

COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 15 October 2026, 8:54 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price219₹ per share

Reported P/E30.8Times

Book value per share41.2₹ per share

Reported ROCE22.7 %Reported return

Stored market and accounting figures

Price record: 15 October 2026, 8:54 pm +05:30. Not a live quote.

Measure	Stored figure
Market Cap	1,446 Cr.
Current Price	219
High / Low	265/155
Stock P/E	30.8
Book Value	41.2
Dividend Yield	1.83 %
ROCE	22.7 %
ROE	17.3 %
Face Value	2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Jun 2026

Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 7.9% to ₹82 crore against Jun 2025. Net profit rose 18.2% to ₹13 crore against the same period a year earlier. Operating margin rose from 18.4% to 20.7% (2.3 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

Metric	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	60	58	47	43	61	75	74	59	76	74	73	64	82
Expenses	52	49	44	41	51	58	58	50	61	58	57	53	65
Operating Profit	9	8	3	3	10	16	16	9	14	16	16	11	17
OPM %	14%	14%	7%	6%	17%	22%	21%	15%	19%	22%	22%	17%	21%
Other Income	2	2	3	2	-2	2	26	3	3	3	1	3	3
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	1	2	2	2	2	2	2	2	2
Profit before tax	10	10	5	5	7	15	39	9	14	17	15	12	18
Tax %	26%	25%	25%	22%	25%	25%	17%	24%	25%	25%	25%	25%	25%
Net Profit	7	7	4	4	5	11	32	7	11	13	11	9	13
EPS in Rs	1.14	1.14	0.60	0.54	0.81	1.73	4.82	0.99	1.62	1.89	1.64	1.31	2.00

Last Updated: September 29, 2026, 7:44 pm

EARNINGS

Annual performance

Mar 2026

Higher sales were accompanied by lower earnings in the year ending Mar 2026. Sales rose 6.7% to ₹287 crore against Mar 2025. Net profit fell 21.8% to ₹43 crore against the same period a year earlier. Operating margin rose from 19.0% to 20.2% (1.2 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 3:16 am

Metric	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	138	143	144	127	167	159	188	218	237	209	269	287	294
Expenses	129	132	138	138	157	150	169	192	203	186	218	229	233
Operating Profit	9	12	6	-11	9	9	19	26	34	23	51	58	61
OPM %	6%	8%	4.0%	-9%	6%	5%	10%	12%	14%	11%	19%	20%	21%
Other Income	0	1	13	0	1	3	4	3	2	9	28	10	10
Interest	4	5	3	1	1	1	1	0	0	1	1	1	1
Depreciation	3	3	2	0	1	1	1	2	1	2	8	9	9
Profit before tax	2	4	14	-12	9	9	22	27	35	30	70	58	61
Tax %	30%	20%	18%	-1%	20%	16%	22%	29%	23%	25%	21%	25%
Net Profit	1	3	12	-12	7	8	17	19	27	22	55	43	45
EPS in Rs	0.18	0.50	1.81	-1.76	1.10	1.20	2.60	2.88	4.08	3.40	8.34	6.43	6.84
Dividend Payout %	22%	8%	2%	-2%	9%	17%	15%	56%	49%	59%	30%	62%

Year-on-year profit growth table

YoY Net Profit Growth

Year	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025	2025-2026
YoY Net Profit Growth (%)	200.00%	300.00%	-200.00%	158.33%	14.29%	112.50%	11.76%	42.11%	-18.52%	150.00%	-21.82%
Change in YoY Net Profit Growth (%)	0.00%	100.00%	-500.00%	358.33%	-144.05%	98.21%	-100.74%	30.34%	-60.62%	168.52%	-171.82%

Growth

Compounded Sales Growth
10 Years:	7%
5 Years:	11%
3 Years:	7%
TTM:	35%

Compounded Profit Growth
10 Years:	42%
5 Years:	38%
3 Years:	29%
TTM:	87%

Stock Price CAGR
10 Years:	36%
5 Years:	75%
3 Years:	16%
1 Year:	45%

Return on Equity
10 Years:	10%
5 Years:	16%
3 Years:	17%
Last Year:	19%

Last Updated: September 5, 2025, 8:00 am

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹8.00 crore in Mar 2026. They decreased from ₹9.00 crore in Mar 2025 (11.1% lower). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: October 4, 2026, 8:55 pm

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	13	13	13	13	13	13	13	13	13	13	13	13
Reserves	82	85	97	85	91	98	109	120	146	174	227	263
Borrowings	39	38	8	8	4	5	7	0	6	9	9	8
Other Liabilities	19	22	25	23	28	31	35	31	30	21	29	32
Total Liabilities	154	159	143	130	136	147	164	164	195	217	278	317
Fixed Assets	52	52	22	21	22	22	26	23	24	9	94	85
CWIP	0	0	0	3	4	4	0	0	0	0	0	0
Investments	0	0	0	0	0	11	15	51	1	0	0	0
Other Assets	102	108	121	105	110	109	123	91	170	208	184	231
Total Assets	154	159	143	130	136	147	164	164	195	217	278	317

CASH & FUNDING

Cash generation

Mar 2026

Operating activities generated ₹47 crore in Mar 2026. Reported free cash flow for the same period was ₹47 crore. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business. Operating cash flow was equivalent to 109.3% of the ₹43 crore reported annual profit for the same year ending Mar 2026, before capital expenditure.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	4	9	-3	-2	31	11	28	7	47	35	55	47
Cash from Investing Activity +	-0	-2	41	-3	-1	-11	-2	-26	-58	-25	-45	-36
Cash from Financing Activity +	-1	-6	-34	-1	-6	-1	-7	-18	-0	-9	-12	-12
Net Cash Flow	2	1	5	-6	24	-0	19	-36	-11	2	-2	-1
Free Cash Flow	4	6	40	-5	30	12	28	6	48	35	90	47
CFO/OP	53%	83%	-6%	14%	311%	150%	164%	54%	158%	189%	124%	101%
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	53%	83%	-6%	14%	311%	150%	164%	54%	158%	189%	124%	101%

Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
Period	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Free Cash Flow	4.00	6.00	40.00	-5.00	30.00	12.00	28.00	6.00	48.00	35.00	90.00	47.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 9 in Mar 2025. That is 43 days lower than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

CAPITAL RETURNS

Returns on capital & equity

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	115	119	106	100	73	45	49	25	26	32	19	18
Inventory Days	173	176	246	295	307	164	191	134	122	82	68	58
Days Payable	29	42	60	56	54	59	76	82	76	66	35	37
Cash Conversion Cycle	259	252	292	339	325	150	164	77	72	48	53	39
Working Capital Days	64	68	72	154	149	67	55	32	59	34	52	9
ROCE %	6%	5%	7%	3%	-10%	9%	9%	18%	20%	25%	17%	23%

SHAREHOLDERS

Ownership trends

Jun 2026

Promoters held 69.06% in Jun 2026. Their share was 1.41 percentage points higher than in Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction. DIIs held 0.62% in Jun 2026, 0.57 percentage points above their holding in Jun 2025. FIIs held 2.30% in Jun 2026, 0.13 percentage points above their holding in Jun 2025.

Shareholding comparison

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

SHAREHOLDER PARTICIPATION

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

Month	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	68.72%	68.48%	68.09%	68.04%	67.98%	67.82%	67.77%	67.65%	67.54%	67.39%	67.89%	69.06%
FIIs	0.38%	0.53%	0.73%	1.10%	2.30%	2.10%	2.10%	2.17%	2.12%	2.12%	2.44%	2.30%
DIIs	0.82%	0.82%	0.84%	0.84%	0.11%	0.00%	0.00%	0.05%	0.08%	0.15%	0.22%	0.62%
Public	30.07%	30.16%	30.33%	30.01%	29.63%	30.10%	30.11%	30.12%	30.25%	30.34%	29.44%	28.04%
No. of Shareholders	16,041	15,785	16,282	15,748	15,633	18,471	21,085	22,899	24,653	24,895	26,264	24,181

Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Motilal Oswal S&P BSE Healthcare ETF	83	0.04	0	83	2025-04-22 17:25:30	0%

ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Distributions & retention

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	2.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	8.26	8.49	10.20	7.48	6.51
Diluted EPS (Rs.)	8.22	8.46	10.20	7.48	6.51
Cash EPS (Rs.)	9.56	9.13	10.66	8.06	6.71
Book Value[Excl.RevalReserv]/Share (Rs.)	36.08	70.88	60.65	46.96	43.55
Book Value[Incl.RevalReserv]/Share (Rs.)	36.08	70.88	60.65	49.95	46.54
Dividend / Share (Rs.)	2.50	5.00	5.00	4.00	1.00
Revenue From Operations / Share (Rs.)	40.47	78.94	90.36	86.30	71.74
PBDIT / Share (Rs.)	8.92	12.23	15.22	11.12	8.96
PBIT / Share (Rs.)	7.70	11.61	14.76	10.54	8.76
PBT / Share (Rs.)	10.52	11.30	13.29	10.43	8.35
Net Profit / Share (Rs.)	8.34	8.50	10.20	7.48	6.51
PBDIT Margin (%)	22.05	15.49	16.84	12.88	12.48
PBIT Margin (%)	19.02	14.70	16.34	12.20	12.21
PBT Margin (%)	25.99	14.31	14.70	12.08	11.63
Net Profit Margin (%)	20.60	10.76	11.28	8.66	9.07
Return on Networth / Equity (%)	23.11	11.98	16.81	15.92	14.95
Return on Capital Employeed (%)	20.26	15.50	23.10	20.55	18.54
Return On Assets (%)	19.89	10.34	13.70	11.62	10.38
Total Debt / Equity (X)	0.00	0.00	0.00	0.00	0.05
Asset Turnover Ratio (%)	1.08	1.01	1.30	1.36	1.21
Current Ratio (X)	6.22	10.42	5.97	3.24	2.98
Quick Ratio (X)	5.64	9.63	5.22	2.37	2.25
Inventory Turnover Ratio (X)	17.80	1.24	1.24	1.36	1.31
Dividend Payout Ratio (NP) (%)	23.89	58.31	0.00	53.50	15.35
Dividend Payout Ratio (CP) (%)	20.83	54.29	0.00	49.63	14.91
Earning Retention Ratio (%)	76.11	41.69	0.00	46.50	84.65
Cash Earning Retention Ratio (%)	79.17	45.71	0.00	50.37	85.09
Interest Coverage Ratio (X)	61.86	39.74	96.57	102.18	21.61
Interest Coverage Ratio (Post Tax) (X)	38.24	28.60	74.08	69.70	16.71
Enterprise Value (Cr.)	1305.18	591.93	644.85	795.42	154.96
EV / Net Operating Revenue (X)	4.86	2.84	2.72	3.52	0.82
EV / EBITDA (X)	22.02	18.30	16.17	27.31	6.60
MarketCap / Net Operating Revenue (X)	5.34	3.54	3.21	3.63	1.11
Retention Ratios (%)	76.10	41.68	0.00	46.49	84.64
Price / BV (X)	5.99	3.95	4.78	6.68	1.83
Price / Net Operating Revenue (X)	5.34	3.54	3.21	3.63	1.11
EarningsYield	0.03	0.03	0.03	0.02	0.08

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Jagsonpal Pharmaceuticals Ltd	1,446 Cr.	219	265/155	30.8	41.2	1.83 %	22.7 %	17.3 %	2.00
Amrutanjan Health Care Ltd	1,456 Cr.	503	760/476	23.4	128	0.97 %	24.8 %	18.4 %	1.00
TTK Healthcare Ltd	1,460 Cr.	1,033	1,250/735	19.1	789	0.97 %	8.04 %	6.30 %	10.0
Kopran Ltd	1,328 Cr.	274	296/107	53.1	110	1.10 %	6.65 %	4.91 %	10.0
Fermenta Biotech Ltd	1,587 Cr.	540	583/249	29.0	138	0.69 %	20.6 %	16.4 %	5.00
Industry Average	17,096.69 Cr	1,204.61		53.02	211.25	0.40%	26.15%	16.59%	6.06

All Competitor Stocks of Jagsonpal Pharmaceuticals Ltd